Edwards Lifesciences Corporation Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Edwards Lifesciences Corporation (EW) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $58.90 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-02-25
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $58.90M, a 5.37% increase from fiscal 2023.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $55.90M, a 28.80% increase from fiscal 2022.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $43.40M, a 10.33% decline from fiscal 2021.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $48.40M, a 12.30% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $58.90M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $55.90M 10-K · filed 2026-02-25 | $62.50M 10-K · filed 2024-02-12 |
| 2022-12-31 | $43.40M 10-K · filed 2025-02-28 | $50.00M 10-K · filed 2023-02-13 |
| 2021-12-31 | $48.40M 10-K · filed 2024-02-12 | |
| 2020-12-31 | $43.10M 10-K · filed 2023-02-13 | |
| 2019-12-31 | $42.90M 10-K · filed 2022-02-14 | |
| 2018-12-31 | $36.70M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $25.80M 10-K · filed 2020-02-14 | |
| 2016-12-31 | $21.30M 10-K · filed 2019-02-15 | |
| 2015-12-31 | $15.70M 10-K · filed 2018-02-16 | |
| 2014-12-31 | $13.50M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $19.80M 10-K · filed 2016-02-19 | |
| 2012-12-31 | $4.90M 10-K · filed 2015-02-20 | |
| 2011-12-31 | $10.40M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |